10/30/2025 | Press release | Distributed by Public on 10/30/2025 08:52
| Fund | Costs of a $10,000 investment | Costs paid as a percentage of a $10,000 investment |
| BNY Mellon Innovators ETF | $27 | 0.50%* |
| * |
Annualized.
|
|
Fund Size (Millions) |
Number of Holdings |
Portfolio Turnover |
| $18 | 50 | 3.25% |
| Fund | Costs of a $10,000 investment | Costs paid as a percentage of a $10,000 investment |
| BNY Mellon Women's Opportunities ETF | $26 | 0.50%* |
| * |
Annualized.
|
|
Fund Size (Millions) |
Number of Holdings |
Portfolio Turnover |
| $17 | 49 | 13.09% |
Item 1. Reports to Stockholders (cont.).
| (b) | Not applicable. |
Item 2. Code of Ethics.
Not applicable.
Item 3. Audit Committee Financial Expert.
Not applicable.
Item 4. Principal Accountant Fees and Services.
Not applicable.
Item 5. Audit Committee of Listed Registrants.
Not applicable.
Item 6. Investments.
| (a) | The Schedule of Investments in securities of unaffiliated issuers as of the close of the Reporting Period is included in the financial statements filed under Item 7 of this Form N-CSR. |
| (b) | Not applicable. |
Item 7. Financial Statements and Financial Highlights for Open-End Management Investment Companies.
The following is a copy of the Registrant's most recent financial statements and financial highlights.
|
Item 7. Financial Statements and Financial Highlights for Open-End Management
Investment Companies
|
3
|
|
Schedule of Investments
|
3
|
|
Statement of Assets and Liabilities
|
6
|
|
Statement of Operations
|
7
|
|
Statement of Changes in Net Assets
|
8
|
|
Financial Highlights
|
9
|
|
Notes to Financial Statements
|
10
|
|
Item 8. Changes in and Disagreements with Accountants for Open-End Management
Investment Companies
|
16
|
|
Item 9. Proxy Disclosures for Open-End Management Investment Companies
|
17
|
|
Item 10. Remuneration Paid to Directors, Officers, and Other of Open-End
Management Investment Companies
|
18
|
|
Item 11. Statement Regarding Basis for Approval of Investment Advisory Contracts
|
19
|
|
Description
|
|
|
|
Shares
|
Value ($)
|
|
Common Stocks - 99.7%
|
|||||
|
Automobiles & Components - 1.5%
|
|||||
|
Tesla, Inc.(a)
|
786
|
262,422
|
|||
|
Capital Goods - 2.0%
|
|||||
|
Axon Enterprise, Inc.(a)
|
474
|
354,215
|
|||
|
Consumer Discretionary Distribution & Retail - 2.7%
|
|||||
|
Chewy, Inc., Cl. A(a)
|
6,352
|
260,178
|
|||
|
PDD Holdings, Inc., ADR(a)
|
1,785
|
214,593
|
|||
|
|
474,771
|
||||
|
Consumer Durables & Apparel - .9%
|
|||||
|
Lululemon Athletica, Inc.(a)
|
780
|
157,716
|
|||
|
Consumer Services - 4.0%
|
|||||
|
Airbnb, Inc., Cl. A(a)
|
1,525
|
199,058
|
|||
|
DraftKings, Inc., Cl. A(a)
|
4,816
|
231,072
|
|||
|
Dutch Bros, Inc., Cl. A(a)
|
3,852
|
276,689
|
|||
|
|
706,819
|
||||
|
Energy - 1.0%
|
|||||
|
Cactus, Inc., Cl. A
|
4,275
|
179,336
|
|||
|
Financial Services - 2.0%
|
|||||
|
Block, Inc.(a)
|
4,376
|
348,505
|
|||
|
Food, Beverage & Tobacco - 3.0%
|
|||||
|
Celsius Holdings, Inc.(a)
|
5,151
|
323,895
|
|||
|
Freshpet, Inc.(a)
|
3,873
|
216,191
|
|||
|
|
540,086
|
||||
|
Health Care Equipment & Services - 12.8%
|
|||||
|
Align Technology, Inc.(a)
|
1,274
|
180,857
|
|||
|
DexCom, Inc.(a)
|
2,594
|
195,432
|
|||
|
Guardant Health, Inc.(a),(b)
|
4,929
|
332,313
|
|||
|
Inspire Medical Systems, Inc.(a)
|
2,464
|
230,852
|
|||
|
Intuitive Surgical, Inc.(a)
|
715
|
338,406
|
|||
|
iRhythm Technologies, Inc.(a)
|
3,747
|
636,915
|
|||
|
Privia Health Group, Inc.(a)
|
6,492
|
149,576
|
|||
|
PROCEPT BioRobotics Corp.(a),(b)
|
1,065
|
42,781
|
|||
|
TransMedics Group, Inc.(a),(b)
|
1,377
|
158,300
|
|||
|
|
2,265,432
|
||||
|
Media & Entertainment - 16.9%
|
|||||
|
Alphabet, Inc., Cl. C
|
5,512
|
1,176,977
|
|||
|
Liberty Media Corp.-Liberty Formula One, Cl. C(a)
|
2,974
|
297,103
|
|||
|
Netflix, Inc.(a)
|
748
|
903,771
|
|||
|
Pinterest, Inc., Cl. A(a)
|
6,341
|
232,271
|
|||
|
Reddit, Inc., Cl. A(a)
|
1,655
|
372,507
|
|||
|
|
2,982,629
|
||||
|
Pharmaceuticals, Biotechnology & Life Sciences - 16.2%
|
|||||
|
Ascendis Pharma A/S, ADR(a)
|
2,002
|
388,929
|
|||
|
Crinetics Pharmaceuticals, Inc.(a),(b)
|
2,332
|
72,269
|
|||
|
Denali Therapeutics, Inc.(a)
|
5,554
|
84,810
|
|||
|
GRAIL, Inc.(a),(b)
|
3,482
|
114,175
|
|||
|
Insmed, Inc.(a)
|
8,426
|
1,146,779
|
|||
|
Natera, Inc.(a)
|
1,774
|
298,475
|
|||
|
Repligen Corp.(a)
|
3,436
|
420,291
|
|||
|
Description
|
|
|
|
Shares
|
Value ($)
|
|
Common Stocks - 99.7% (continued)
|
|||||
|
Pharmaceuticals, Biotechnology & Life Sciences - 16.2% (continued)
|
|||||
|
Twist Bioscience Corp.(a),(b)
|
4,124
|
111,224
|
|||
|
Xenon Pharmaceuticals, Inc.(a)
|
1,879
|
72,736
|
|||
|
Zoetis, Inc.
|
980
|
153,272
|
|||
|
|
2,862,960
|
||||
|
Real Estate Management & Development - 3.5%
|
|||||
|
CoStar Group, Inc.(a)
|
7,010
|
627,325
|
|||
|
Semiconductors & Semiconductor Equipment - 18.8%
|
|||||
|
Broadcom, Inc.
|
1,402
|
416,941
|
|||
|
NVIDIA Corp.
|
16,708
|
2,910,199
|
|||
|
|
3,327,140
|
||||
|
Software & Services - 13.6%
|
|||||
|
Confluent, Inc., Cl. A(a)
|
14,361
|
285,209
|
|||
|
CyberArk Software Ltd.(a)
|
767
|
347,650
|
|||
|
Datadog, Inc., Cl. A(a)
|
2,283
|
312,040
|
|||
|
HubSpot, Inc.(a)
|
182
|
87,937
|
|||
|
Klaviyo, Inc., Cl. A(a)
|
14,372
|
466,228
|
|||
|
Monday.com Ltd.(a)
|
1,141
|
220,213
|
|||
|
Palantir Technologies, Inc., Cl. A(a)
|
1,084
|
169,874
|
|||
|
Shopify, Inc., Cl. A(a)
|
3,624
|
511,999
|
|||
|
|
2,401,150
|
||||
|
Technology Hardware & Equipment - .8%
|
|||||
|
Pure Storage, Inc., Cl. A(a)
|
1,932
|
149,942
|
|||
|
Total Common Stocks
(cost $10,513,070)
|
17,640,448
|
||||
|
|
|
1-Day
Yield (%)
|
|
|
|
|
Investment Companies - .3%
|
|||||
|
Registered Investment Companies - .3%
|
|||||
|
Dreyfus Institutional Preferred Government Money Market Fund, Institutional Shares(c)
(cost $56,778)
|
4.25
|
56,778
|
56,778
|
||
|
Investment of Cash Collateral for Securities Loaned - .7%
|
|||||
|
Registered Investment Companies - .7%
|
|||||
|
Dreyfus Institutional Preferred Government Money Market Fund, Institutional Shares(c)
(cost $119,956)
|
4.25
|
119,956
|
119,956
|
||
|
Total Investments(cost $10,689,804)
|
|
100.7%
|
17,817,182
|
||
|
Liabilities, Less Cash and Receivables
|
|
(.7%)
|
(125,901)
|
||
|
Net Assets
|
100.0%
|
17,691,281
|
|||
|
ADR-American Depositary Receipt
|
|
(a)
|
Non-income producing security.
|
|
(b)
|
Security, or portion thereof, on loan. At August 31, 2025, the value of the fund's securities on loan was $822,615 and the value of the collateral was $830,208,
consisting of cash collateral of $119,956 and U.S. Government & Agency securities valued at $710,252. In addition, the value of collateral may include
pending sales that are also on loan.
|
|
(c)
|
Investment in affiliated issuer. The investment objective of this investment company is publicly available and can be found within the investment company's
prospectus.
|
|
Affiliated Issuers
|
|||||
|
Description
|
Value ($)
2/28/2025
|
Purchases ($)†
|
Sales ($)
|
Value ($)
8/31/2025
|
Dividends/
Distributions ($)
|
|
Registered Investment Companies - .3%
|
|||||
|
Dreyfus Institutional Preferred Government Money Market Fund,
Institutional Shares - .3%
|
52,521
|
227,183
|
(222,926)
|
56,778
|
1,451
|
|
Investment of Cash Collateral for Securities Loaned - .7%
|
|||||
|
Dreyfus Institutional Preferred Government Money Market Fund,
Institutional Shares - .7%
|
-
|
1,247,998
|
(1,128,042)
|
119,956
|
811††
|
|
Total - 1.0%
|
52,521
|
1,475,181
|
(1,350,968)
|
176,734
|
2,262
|
|
†
|
Includes reinvested dividends/distributions.
|
|
††
|
Represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and
other payments to and from borrowers of securities.
|
|
|
Cost
|
Value
|
|
Assets ($):
|
||
|
Investments in securities-See Schedule of Investments
(including securities on loan, valued at $822,615)-Note 2(b):
|
||
|
Unaffiliated issuers
|
10,513,070
|
17,640,448
|
|
Affiliated issuers
|
176,734
|
176,734
|
|
Dividends and securities lending income receivable
|
1,398
|
|
|
|
17,818,580
|
|
|
Liabilities ($):
|
||
|
Due to BNY Mellon ETF Investment Adviser, LLC-Note 3(b)
|
7,343
|
|
|
Liability for securities on loan-Note 2(b)
|
119,956
|
|
|
|
127,299
|
|
|
Net Assets ($)
|
17,691,281
|
|
|
Composition of Net Assets ($):
|
||
|
Paid-in capital
|
11,341,989
|
|
|
Total distributable earnings (loss)
|
6,349,292
|
|
|
Net Assets ($)
|
17,691,281
|
|
|
Shares Outstanding
|
||
|
Shares outstanding no par value (unlimited shares authorized)
|
450,001
|
|
|
Net Asset Value Per Share ($)
|
39.31
|
|
|
Market Price Per Share ($)
|
39.30
|
|
|
|
|
Investment Income ($):
|
|
|
Income:
|
|
|
Dividends:
|
|
|
Unaffiliated issuers
|
4,643
|
|
Affiliated issuers
|
1,451
|
|
Affiliated income net of rebates from securities lending-Note 2(b)
|
811
|
|
Total Income
|
6,905
|
|
Expenses:
|
|
|
Management fee-Note 3(a)
|
39,551
|
|
Total Expenses
|
39,551
|
|
Net Investment Income
|
(32,646
)
|
|
Realized and Unrealized Gain (Loss) on Investments-Note 4 ($):
|
|
|
Net realized gain (loss) on investments
|
(351,622
)
|
|
Net change in unrealized appreciation (depreciation) on investments
|
2,053,237
|
|
Net Realized and Unrealized Gain (Loss) on Investments
|
1,701,615
|
|
Net Increase in Net Assets Resulting from Operations
|
1,668,969
|
|
|
Six Months Ended
August 31, 2025 (Unaudited)
|
Year Ended
February 28, 2025
|
|
|
||
|
Operations ($):
|
||
|
Net investment (loss)
|
(32,646)
|
(47,880)
|
|
Net realized gain (loss) on investments
|
(351,622)
|
(368,758)
|
|
Net change in unrealized appreciation (depreciation) on investments
|
2,053,237
|
2,476,078
|
|
Net Increase (Decrease) in Net Assets Resulting from Operations
|
1,668,969
|
2,059,440
|
|
Total Increase (Decrease) in Net Assets
|
1,668,969
|
2,059,440
|
|
Net Assets ($):
|
||
|
Beginning of Period
|
16,022,312
|
13,962,872
|
|
End of Period
|
17,691,281
|
16,022,312
|
|
|
Six Months Ended
August 31, 2025
(Unaudited)
|
Year Ended
February 28/29,
|
|
|
|
2025
|
2024(a)
|
|
|
Per Share Data ($):
|
|
|
|
|
Net asset value, beginning of period
|
35.61
|
31.03
|
25.00
|
|
Investment Operations:
|
|||
|
Net investment (loss)(b)
|
(.07
)
|
(.11
)
|
(.07
)
|
|
Net realized and unrealized gain (loss) on investments
|
3.77
|
4.69
|
6.09
|
|
Payment by Affiliate
|
-
|
-
|
.01
(c)
|
|
Total from Investment Operations
|
3.70
|
4.58
|
6.03
|
|
Transaction fees(b)
|
-
|
-
|
0.00
(d)
|
|
Net asset value, end of period
|
39.31
|
35.61
|
31.03
|
|
Market value, end of period
|
39.30
|
35.59
|
30.98
|
|
Total Return (%)(e)
|
10.42
|
14.75
|
24.11
(f)
|
|
Market Price Total Return (%)(e)
|
10.43
|
14.88
|
23.92
(f)
|
|
Ratios/Supplemental Data (%):
|
|
|
|
|
Ratio of total expenses to average net assets(g)
|
.50
(h)
|
.50
|
.50
(h)
|
|
Ratio of net investment (loss) to average net assets(g)
|
(.41
)(h)
|
(.32
)
|
(.33
)(h)
|
|
Portfolio Turnover Rate(i)
|
3.25
|
44.08
|
12.39
|
|
Net Assets, end of period ($ x 1,000)
|
17,691
|
16,022
|
13,963
|
|
(a)
|
From May 18, 2023 (commencement of operations) to February 29, 2024.
|
|
(b)
|
Based on average shares outstanding.
|
|
(c)
|
The total return for the fund was not materially impacted by the reimbursement to the fund for fund losses relating to trade processing error.
|
|
(d)
|
Amount represents less than $.01 per share.
|
|
(e)
|
Net asset value total return is calculated assuming an initial investment made at the net asset value at the beginning of the period, reinvestment of all dividends
and distributions at net asset value during the period, and redemption at net asset value on the last day of the period. Net asset value total return includes
adjustments in accordance with accounting principles generally accepted in the United States of America and as such, the net asset value for financial reporting
purposes and the returns based upon those net asset values may differ from the net asset value and returns for shareholder transactions. Market price total return is
calculated assuming an initial investment made at the market price at the beginning of the period, reinvestment of all dividends and distributions at market price
during the period, and sale at the market price on the last day of the period. Total investment returns calculated for a period of less than one year are not annualized.
|
|
(f)
|
The net asset value total return and the market price total return is calculated from fund inception. The inception date is the first date the fund was available on
The NASDAQ Stock Market LLC.
|
|
(g)
|
Amount does not include the expenses of the underlying funds.
|
|
(h)
|
Annualized.
|
|
(i)
|
Portfolio turnover rate is not annualized for periods less than one year, if applicable, and does not include securities received or delivered from processing creations
or redemptions.
|
|
|
Level 1 -
Unadjusted
Quoted Prices
|
Level 2- Other
Significant
Observable Inputs
|
Level 3-
Significant
Unobservable
Inputs
|
Total
|
|
Assets ($)
|
||||
|
Investments in Securities:†
|
||||
|
Equity Securities - Common Stocks
|
17,640,448
|
-
|
-
|
17,640,448
|
|
Investment Companies
|
176,734
|
-
|
-
|
176,734
|
|
|
17,817,182
|
-
|
-
|
17,817,182
|
|
†
|
See Schedule of Investments for additional detailed categorizations, if any.
|
|
Assets ($)
|
|
|
Gross amount of securities loaned, at
value, as disclosed in the Statement
of Assets and Liabilities
|
822,615
|
|
Collateral (received)/posted not offset
in the Statement of
Assets and Liabilities
|
(822,615
)†
|
|
Net amount
|
-
|
|
†
|
The value of the related collateral received by the fund exceeded the value of the securities loaned by the fund pursuant to the securities lending agreement. In addition,
the value of collateral may include pending sales that are also on loan. See Schedule of Investments for detailed information regarding collateral received for open
securities lending.
|
|
Item 7. Financial Statements and Financial Highlights for Open-End Management
Investment Companies
|
3
|
|
Schedule of Investments
|
3
|
|
Statement of Assets and Liabilities
|
6
|
|
Statement of Operations
|
7
|
|
Statement of Changes in Net Assets
|
8
|
|
Financial Highlights
|
9
|
|
Notes to Financial Statements
|
10
|
|
Item 8. Changes in and Disagreements with Accountants for Open-End Management
Investment Companies
|
16
|
|
Item 9. Proxy Disclosures for Open-End Management Investment Companies
|
17
|
|
Item 10. Remuneration Paid to Directors, Officers, and Other of Open-End
Management Investment Companies
|
18
|
|
Item 11. Statement Regarding Basis for Approval of Investment Advisory Contracts
|
19
|
|
Description
|
|
|
|
Shares
|
Value ($)
|
|
Common Stocks - 99.4%
|
|||||
|
Banks - 8.1%
|
|||||
|
Bank of America Corp.
|
7,062
|
358,326
|
|||
|
First Horizon Corp.
|
10,673
|
241,210
|
|||
|
JPMorgan Chase & Co.
|
2,534
|
763,798
|
|||
|
|
1,363,334
|
||||
|
Capital Goods - 6.2%
|
|||||
|
Axon Enterprise, Inc.(a)
|
300
|
224,187
|
|||
|
GE Vernova, Inc.
|
415
|
254,383
|
|||
|
Hubbell, Inc.
|
415
|
178,861
|
|||
|
Trane Technologies PLC
|
954
|
396,482
|
|||
|
|
1,053,913
|
||||
|
Commercial & Professional Services - 1.6%
|
|||||
|
Veralto Corp.
|
2,553
|
271,103
|
|||
|
Consumer Discretionary Distribution & Retail - 7.7%
|
|||||
|
Amazon.com, Inc.(a)
|
4,815
|
1,102,635
|
|||
|
The TJX Companies, Inc.
|
1,440
|
196,718
|
|||
|
|
1,299,353
|
||||
|
Consumer Services - 1.7%
|
|||||
|
Bright Horizons Family Solutions, Inc.(a)
|
2,426
|
286,365
|
|||
|
Consumer Staples Distribution & Retail - 1.6%
|
|||||
|
Walmart, Inc.
|
2,859
|
277,266
|
|||
|
Energy - 2.7%
|
|||||
|
ConocoPhillips
|
1,357
|
134,302
|
|||
|
EQT Corp.
|
4,132
|
214,203
|
|||
|
Phillips 66
|
811
|
108,333
|
|||
|
|
456,838
|
||||
|
Financial Services - 4.3%
|
|||||
|
CME Group, Inc.
|
789
|
210,276
|
|||
|
Mastercard, Inc., Cl. A
|
882
|
525,046
|
|||
|
|
735,322
|
||||
|
Health Care Equipment & Services - 8.8%
|
|||||
|
Abbott Laboratories
|
1,878
|
249,135
|
|||
|
Addus HomeCare Corp.(a)
|
1,278
|
147,187
|
|||
|
Alcon AG
|
1,917
|
152,996
|
|||
|
Boston Scientific Corp.(a)
|
4,123
|
434,976
|
|||
|
DexCom, Inc.(a)
|
2,387
|
179,837
|
|||
|
IDEXX Laboratories, Inc.(a)
|
274
|
177,303
|
|||
|
Intuitive Surgical, Inc.(a)
|
297
|
140,569
|
|||
|
|
1,482,003
|
||||
|
Household & Personal Products - 3.7%
|
|||||
|
Kenvue, Inc.
|
7,089
|
146,813
|
|||
|
The Estee Lauder Companies, Inc., Cl. A
|
2,077
|
190,523
|
|||
|
The Procter & Gamble Company
|
1,884
|
295,864
|
|||
|
|
633,200
|
||||
|
Insurance - 2.2%
|
|||||
|
Aon PLC, Cl. A
|
558
|
204,786
|
|||
|
Assurant, Inc.
|
755
|
162,786
|
|||
|
|
367,572
|
||||
|
Description
|
|
|
|
Shares
|
Value ($)
|
|
Common Stocks - 99.4% (continued)
|
|||||
|
Media & Entertainment - 6.0%
|
|||||
|
Meta Platforms, Inc., Cl. A
|
998
|
737,222
|
|||
|
The Walt Disney Company
|
2,331
|
275,944
|
|||
|
|
1,013,166
|
||||
|
Pharmaceuticals, Biotechnology & Life Sciences - 5.1%
|
|||||
|
AbbVie, Inc.
|
2,428
|
510,851
|
|||
|
AstraZeneca PLC, ADR
|
2,884
|
230,432
|
|||
|
Natera, Inc.(a)
|
752
|
126,524
|
|||
|
|
867,807
|
||||
|
Real Estate Management & Development - 1.1%
|
|||||
|
CoStar Group, Inc.(a)
|
2,001
|
179,069
|
|||
|
Semiconductors & Semiconductor Equipment - 12.9%
|
|||||
|
Micron Technology, Inc.
|
1,977
|
235,283
|
|||
|
NVIDIA Corp.
|
10,197
|
1,776,113
|
|||
|
Texas Instruments, Inc.
|
851
|
172,311
|
|||
|
|
2,183,707
|
||||
|
Software & Services - 17.4%
|
|||||
|
HubSpot, Inc.(a)
|
536
|
258,979
|
|||
|
Intuit, Inc.
|
558
|
372,186
|
|||
|
Microsoft Corp.
|
2,977
|
1,508,416
|
|||
|
ServiceNow, Inc.(a)
|
222
|
203,676
|
|||
|
Shopify, Inc., Cl. A(a)
|
2,551
|
360,406
|
|||
|
Synopsys, Inc.(a)
|
389
|
234,769
|
|||
|
|
2,938,432
|
||||
|
Technology Hardware & Equipment - 4.6%
|
|||||
|
Apple, Inc.
|
3,348
|
777,205
|
|||
|
Transportation - .9%
|
|||||
|
Uber Technologies, Inc.(a)
|
1,619
|
151,781
|
|||
|
Utilities - 2.8%
|
|||||
|
Constellation Energy Corp.
|
878
|
270,406
|
|||
|
Dominion Energy, Inc.
|
3,273
|
196,053
|
|||
|
|
466,459
|
||||
|
Total Common Stocks
(cost $11,560,676)
|
16,803,895
|
||||
|
|
|
1-Day
Yield (%)
|
|
|
|
|
Investment Companies - .6%
|
|||||
|
Registered Investment Companies - .6%
|
|||||
|
Dreyfus Institutional Preferred Government Money Market Fund, Institutional Shares(b)
(cost $98,694)
|
4.25
|
98,694
|
98,694
|
||
|
Total Investments(cost $11,659,370)
|
|
100.0%
|
16,902,589
|
||
|
Cash and Receivables (Net)
|
|
(.0%)
|
1,902
|
||
|
Net Assets
|
100.0%
|
16,904,491
|
|||
|
ADR-American Depositary Receipt
|
|
(a)
|
Non-income producing security.
|
|
(b)
|
Investment in affiliated issuer. The investment objective of this investment company is publicly available and can be found within the investment company's
prospectus.
|
|
Affiliated Issuers
|
|||||
|
Description
|
Value ($)
2/28/2025
|
Purchases ($)†
|
Sales ($)
|
Value ($)
8/31/2025
|
Dividends/
Distributions ($)
|
|
Registered Investment Companies - .6%
|
|||||
|
Dreyfus Institutional Preferred Government Money Market Fund,
Institutional Shares - .6%
|
147,969
|
418,158
|
(467,433)
|
98,694
|
3,571
|
|
Investment of Cash Collateral for Securities Loaned - .0%
|
|||||
|
Dreyfus Institutional Preferred Government Money Market Fund,
Institutional Shares - .0%
|
-
|
233,115
|
(233,115)
|
-
|
3††
|
|
Total - .6%
|
147,969
|
651,273
|
(700,548)
|
98,694
|
3,574
|
|
†
|
Includes reinvested dividends/distributions.
|
|
††
|
Represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and
other payments to and from borrowers of securities.
|
|
|
Cost
|
Value
|
|
Assets ($):
|
||
|
Investments in securities-See Schedule of Investments:
|
||
|
Unaffiliated issuers
|
11,560,676
|
16,803,895
|
|
Affiliated issuers
|
98,694
|
98,694
|
|
Dividends receivable
|
9,087
|
|
|
|
16,911,676
|
|
|
Liabilities ($):
|
||
|
Due to BNY Mellon ETF Investment Adviser, LLC-Note 3(b)
|
7,185
|
|
|
|
7,185
|
|
|
Net Assets ($)
|
16,904,491
|
|
|
Composition of Net Assets ($):
|
||
|
Paid-in capital
|
11,785,876
|
|
|
Total distributable earnings (loss)
|
5,118,615
|
|
|
Net Assets ($)
|
16,904,491
|
|
|
Shares Outstanding
|
||
|
Shares outstanding no par value (unlimited shares authorized)
|
450,001
|
|
|
Net Asset Value Per Share ($)
|
37.57
|
|
|
Market Price Per Share ($)
|
37.55
|
|
|
|
|
Investment Income ($):
|
|
|
Income:
|
|
|
Dividends (net of $231 foreign taxes withheld at source):
|
|
|
Unaffiliated issuers
|
68,289
|
|
Affiliated issuers
|
3,571
|
|
Affiliated income net of rebates from securities lending-Note 2(c)
|
3
|
|
Total Income
|
71,863
|
|
Expenses:
|
|
|
Management fee-Note 3(a)
|
39,272
|
|
Total Expenses
|
39,272
|
|
Net Investment Income
|
32,591
|
|
Realized and Unrealized Gain (Loss) on Investments-Note 4 ($):
|
|
|
Net realized gain (loss) on investments
|
(157,112
)
|
|
Net change in unrealized appreciation (depreciation) on investments
|
1,438,694
|
|
Net Realized and Unrealized Gain (Loss) on Investments
|
1,281,582
|
|
Net Increase in Net Assets Resulting from Operations
|
1,314,173
|
|
|
Six Months Ended
August 31, 2025 (Unaudited)
|
Year Ended
February 28, 2025
|
|
|
||
|
Operations ($):
|
||
|
Net investment income
|
32,591
|
52,417
|
|
Net realized gain (loss) on investments
|
(157,112)
|
156,650
|
|
Net change in unrealized appreciation (depreciation) on investments
|
1,438,694
|
1,143,726
|
|
Net Increase (Decrease) in Net Assets Resulting from Operations
|
1,314,173
|
1,352,793
|
|
Distributions ($):
|
||
|
Distributions to shareholders
|
(100,953)
|
(50,124)
|
|
Beneficial Interest Transactions ($):
|
||
|
Net proceeds from shares sold
|
-
|
1,785,847
|
|
Increase (Decrease) in Net Assets from Beneficial Interest
Transactions
|
-
|
1,785,847
|
|
Total Increase (Decrease) in Net Assets
|
1,213,220
|
3,088,516
|
|
Net Assets ($):
|
||
|
Beginning of Period
|
15,691,271
|
12,602,755
|
|
End of Period
|
16,904,491
|
15,691,271
|
|
Capital Share Transactions (Shares):
|
||
|
Shares sold
|
-
|
50,000
|
|
Net Increase (Decrease) in Shares Outstanding
|
-
|
50,000
|
|
|
Six Months Ended
August 31, 2025
(Unaudited)
|
Year Ended
February 28/29,
|
|
|
|
2025
|
2024(a)
|
|
|
Per Share Data ($):
|
|
|
|
|
Net asset value, beginning of period
|
34.87
|
31.51
|
25.00
|
|
Investment Operations:
|
|||
|
Net investment income(b)
|
.07
|
.13
|
.11
|
|
Net realized and unrealized gain (loss) on investments
|
2.85
|
3.36
|
6.48
|
|
Total from Investment Operations
|
2.92
|
3.49
|
6.59
|
|
Distributions:
|
|||
|
Dividends from net investment income
|
(.03
)
|
(.13
)
|
(.08
)
|
|
Dividends from net realized gain on investments
|
(.19
)
|
-
|
-
|
|
Total Distributions
|
(.22
)
|
(.13
)
|
(.08
)
|
|
Transaction fees(b)
|
-
|
-
|
0.00
(c)
|
|
Net asset value, end of period
|
37.57
|
34.87
|
31.51
|
|
Market value, end of period
|
37.55
|
34.92
|
31.55
|
|
Total Return (%)(d)
|
8.40
|
11.07
|
26.36
(e)
|
|
Market Price Total Return (%)(d)
|
8.20
|
11.08
|
26.53
(e)
|
|
Ratios/Supplemental Data (%):
|
|
|
|
|
Ratio of total expenses to average net assets(f)
|
.50
(g)
|
.50
|
.50
(g)
|
|
Ratio of net investment income to average net assets(f)
|
.41
(g)
|
.39
|
.50
(g)
|
|
Portfolio Turnover Rate(h)
|
13.09
|
44.26
|
24.71
|
|
Net Assets, end of period ($ x 1,000)
|
16,904
|
15,691
|
12,603
|
|
(a)
|
From May 18, 2023 (commencement of operations) to February 29, 2024.
|
|
(b)
|
Based on average shares outstanding.
|
|
(c)
|
Amount represents less than $.01 per share.
|
|
(d)
|
Net asset value total return is calculated assuming an initial investment made at the net asset value at the beginning of the period, reinvestment of all dividends
and distributions at net asset value during the period, and redemption at net asset value on the last day of the period. Net asset value total return includes
adjustments in accordance with accounting principles generally accepted in the United States of America and as such, the net asset value for financial reporting
purposes and the returns based upon those net asset values may differ from the net asset value and returns for shareholder transactions. Market price total return is
calculated assuming an initial investment made at the market price at the beginning of the period, reinvestment of all dividends and distributions at market price
during the period, and sale at the market price on the last day of the period. Total investment returns calculated for a period of less than one year are not annualized.
|
|
(e)
|
The net asset value total return and the market price total return is calculated from fund inception. The inception date is the first date the fund was available on
The NASDAQ Stock Market LLC.
|
|
(f)
|
Amount does not include the expenses of the underlying funds.
|
|
(g)
|
Annualized.
|
|
(h)
|
Portfolio turnover rate is not annualized for periods less than one year, if applicable, and does not include securities received or delivered from processing creations
or redemptions.
|
|
|
Level 1 -
Unadjusted
Quoted Prices
|
Level 2- Other
Significant
Observable Inputs
|
Level 3-
Significant
Unobservable
Inputs
|
Total
|
|
Assets ($)
|
||||
|
Investments in Securities:†
|
||||
|
Equity Securities - Common Stocks
|
16,803,895
|
-
|
-
|
16,803,895
|
|
Investment Companies
|
98,694
|
-
|
-
|
98,694
|
|
|
16,902,589
|
-
|
-
|
16,902,589
|
|
†
|
See Schedule of Investments for additional detailed categorizations, if any.
|
Item 12. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.
Not applicable.
Item 13. Portfolio Managers of Closed-End Management Investment Companies.
Not applicable.
Item 14. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.
Not applicable.
Item 15. Submission of Matters to a Vote of Security Holders.
There have been no material changes to the procedures by which the shareholders may recommend nominees to the Registrant's Board of Trustees, where those changes were implemented after the Registrant last provided disclosure in response to the requirements of Item 407(c)(2)(iv) of Regulation S-K (17 CFR 229.407) (as required by Item 22(b)(15) of Schedule 14A (17 CFR 240.14a-101)), or this Item.
Item 16. Controls and Procedures.
| (a) | The Registrant's principal executive and principal financial officers, or persons performing similar functions, have concluded that the Registrant's disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940, as amended (the "1940 Act") (17 CFR 270.30a-3(c))) are effective, as of a date within 90 days of the filing date of the report that includes the disclosure required by this paragraph, based on their evaluation of these controls and procedures required by Rule 30a-3(b) under the 1940 Act (17 CFR 270.30a-3(b)) and Rules 13a-15(b) or 15d-15(b) under the Securities Exchange Act of 1934, as amended (17 CFR 240.13a-15(b) or 240.15d-15(b)). |
| (b) | There were no changes in the Registrant's internal control over financial reporting (as defined in Rule 30a-3(d) under the 1940 Act (17 CFR 270.30a-3(d))) that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting. |
Item 17. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.
Not applicable.
Item 18. Recovery of Erroneously Awarded Compensation.
Not Applicable.
Item 19. Exhibits.
| (a)(1) | Not applicable. |
| (a)(2) | Not applicable. |
| (a)(3) | Certifications pursuant to Rule 30a-2(a) under the 1940 Act and Section 302 of the Sarbanes-Oxley Act of 2002 are attached hereto. |
| (a)(4) | Not applicable. |
| (a)(5) | Not applicable. |
| (b) | Certifications pursuant to Rule 30a-2(b) under the 1940 Act and Section 906 of the Sarbanes-Oxley Act of 2002 are attached hereto. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
(Registrant)BNY Mellon ETF Trust
| By (Signature and Title) * |
/s/ David J. DiPetrillo (Principal Executive Officer) |
Date10/24/2025
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| By (Signature and Title) * |
/s/ David J. DiPetrillo (Principal Executive Officer) |
Date10/24/2025
| By (Signature and Title) * |
/s/ James Windels (Principal Financial and Accounting Officer) |
Date10/23/2025
* Print the name and title of each signing officer under his or her signature.